Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Askys completes daily dialysis clinical trial:

This article was originally published in Clinica

Executive Summary

Aksys appears to be on track with its plan for submitting a 510(k) clearance application for its Personal Hemodialysis (PHD) system to the US FDA later this year, following the completion of a 25-patient clinical trial of the device. The number of treatments performed using the PHD system during the trial was equal to over 13 years of conventional three times per week dialysis, including over ten years of conventional treatment at home, said the Lincolnshire, Illinois company.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT075211

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel